Navigation Links
Delcath Prices $20 Million Public Offering of Common Stock and Warrants
Date:5/25/2012

ry prospectus supplement related to the offering was filed with the Securities and Exchange Commission on May 24, 2012. The securities may be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. Copies of the prospectus supplement and accompanying prospectus relating to the offering may be obtained, when available, from Cowen and Company, LLC (c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, Phone: 631-274-2806, Fax: 631-254-7140) and from Wedbush Securities Inc. (One Bush Street, 17th floor, San Francisco, CA 94104, Attn:  SF Prospectus Department, Phone: 415-274-6819, Fax: 415-274-6887). An electronic copy of the prospectus supplement and accompanying prospectus relating to the offering is available on the website of the Securities and Exchange Commission at www.sec.gov

This press release does not constitute an offer to sell or the solicitation of offers to buy any securities of Delcath, and shall not constitute an offer, solicitation or sale of any security in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.About Delcath SystemsDelcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath announced that its randomized Phase III clinical trial for patients with metastatic melanoma in the liver had successfully achieved the study's primary endpoint of extended hepatic progress
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... Disorders Drug Pipeline Insight 2014" report to their offering. ... in US is one of the largest segments of pharmaceuticals ... alarming rate, while the available therapies were unable to meet ... in the market for CNS disorder, especially over the past ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Development Trend Forecast of Pharmaceutical Equipment Market in China, ... Research and Development Trend Forecast of Pharmaceutical Equipment Market ... China,s pharmaceutical equipment industry in ... competition landscape, and business performance of domestic major enterprises, ...
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... Company to present interim results from phase 2 trial of novel ... ... NEW HAVEN, Conn., April 3, 2008 Rib-X Pharmaceuticals,Inc. ("Rib-X" ... of novel antibiotics for the treatment of,antibiotic-resistant infections, today announced that ...
... Proof-of-Principle Studies -, GAITHERSBURG, Md., April 3, ... announced that it has signed an agreement,with Merck ... the use of the Iomai needle-free immunostimulant patch., ... exclusive license. These,preclinical proof-of-principle studies will be conducted ...
Cached Medicine Technology:Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference 2Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 2Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 3
(Date:8/29/2014)... UWDress.com, one of the most famous dress ... of 2014 floor length bridesmaid dresses . Additionally, ... items. According to the company’s marketing specialist, all its ... rate (up to 60 percent off) before September 10. ... special neckline: strapless, one-shoulder, bateau and more. The main ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to new ... But Not Peer Pressure, Key to Prescription Drug Misuse Among ... primary focus for 18-29 year olds when it comes to ... the for this age group the real problem which influences ... drug associations and recreational use of them to have fun ...
(Date:8/29/2014)... Healthpointe is proud to welcome to ... will be practicing out of Healthpointe’s newest office directly ... Healthpointe’s orthopedic team, Dr. Rodas is board-certified ... in occupational medicine. , Among Dr. Rodas’ many ... of Raytheon, the world-class defense and aerospace company. Additionally, ...
(Date:8/29/2014)... regarded audiologist , Dr. Mary Ann Larkin has written 4 ... are titled:, , Revealing the Truth About Tinnitus ... The Top 5 Things You Should Know Before Buying a ... , Dr. Mary Anne Larkin choose to write about ... misinformation about each them. The reports are available for immediate ...
(Date:8/29/2014)... Healthpointe Medical Group, one of Southern California’s ... LAXMed. The medical center is less than 2 miles from ... the 405 freeway. , The LAX clinic marks the ... is located at: 8610 S. Sepulveda Blvd., Suite 204 Los ... LAX office will provide the same comprehensive services as Healthpointe’s ...
Breaking Medicine News(10 mins):Health News:2014 Floor Length Bridesmaid Dresses for Sale at UWDress.com 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3Health News:Dr. Anthony G. Rodas Joins Healthpointe Team at LAX Office 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:Healthpointe Obtains a New Medical Clinic in the LAX Area 2
... ... Pediatric Surgery , ... 16, 2009 -- Children,s National Medical Center today announced that it will create a new ... of Abu Dhabi. , , ,"This is a great day for Children,s National, but it,s ...
... , Pocono Medical Center and facilities ... of laboratory errors due to specimen mislabeling , ... northeast Pennsylvania have come together to reduce and eliminate laboratory errors ... effort when they noticed they were reporting a large number of ...
... FORT LAUDERDALE, Fla. and BEVERLY HILLS, Calif., Sept. 16 As ... for ways to supplement their income. In response, a new ... event at the Sofitel Hotel in Beverly Hills to introduce its ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090916/NY76803 ) , (Logo: ...
... , , , WASHINGTON, ... by U.S. Senate Finance Committee Chairman Max Baucus (D-MT) will ... health coverage, while letting insurance companies charge what they please ... the most successful insurance premium regulation law in the nation, ...
... , , ... Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced ... Trademark Office has issued a Notice of Allowance for Milestone,s ... Dynamic Pressure Sensing." , , ...
... ... CSL), one of the world,s leading manufacturers of influenza vaccine, announced that the U.S. ... licensure of its monovalent pandemic (H1N1) 2009 influenza A vaccine for active immunization of ... , ...
Cached Medicine News:Health News:New Surgery Institute at Children's National Medical Center Aims to Improve Surgery and Eliminate Pain 2Health News:New Surgery Institute at Children's National Medical Center Aims to Improve Surgery and Eliminate Pain 3Health News:New Surgery Institute at Children's National Medical Center Aims to Improve Surgery and Eliminate Pain 4Health News:Pennsylvania Patient Safety Authority Releases September Advisory 2Health News:Pennsylvania Patient Safety Authority Releases September Advisory 3Health News:Pennsylvania Patient Safety Authority Releases September Advisory 4Health News:Pennsylvania Patient Safety Authority Releases September Advisory 5Health News:livethesource(TM) Hosts Company Launch Event While Supporting The Brent Shapiro Foundation's Annual Sober Night Out 2Health News:livethesource(TM) Hosts Company Launch Event While Supporting The Brent Shapiro Foundation's Annual Sober Night Out 3Health News:Baucus Health Plan Won't Rein in Health Insurer Price Gouging of Middle Class; Consumer Watchdog Calls for 'Prior Approval' Rate Regulation in Health Reform 2Health News:Baucus Health Plan Won't Rein in Health Insurer Price Gouging of Middle Class; Consumer Watchdog Calls for 'Prior Approval' Rate Regulation in Health Reform 3Health News:Milestone Scientific Receives Notice of Allowance From U.S. Patent and Trademark Office 2Health News:Milestone Scientific Receives Notice of Allowance From U.S. Patent and Trademark Office 3Health News:Milestone Scientific Receives Notice of Allowance From U.S. Patent and Trademark Office 4Health News:CSL Biotherapies Announces FDA Marketing Approval of its Monovalent Pandemic (H1N1) 2009 Influenza A Vaccine 2
... American Industrial Laboratories, Inc. specializes in ... eyebank and laboratory specular microscopes, digital ... camera digital upgrade package. Our software ... image data correlation with rapid image ...
... management software is a full-featured product ... clinical aspects of the ophthalmic practice. ... for the financial, administrative and clinical ... professional. Designed as a scaleable solution, ...
The ReSeeVit Slit Lamp System is an easy-to-use digital video imaging system that captures anterior segment and retinal images for documentation, diagnosis and patient education. The package includes...
... The 2V slit lamp ... slit lamp that is ... illumination tower and has ... magnification. Revolutionary design provides ...
Medicine Products: